Cargando…

Role of insulin-like growth factor 1 receptor signalling in cancer

The insulin-like growth factor (IGF-1) signalling is highly implicated in cancer. In this signalling the IGF-1 receptor (IGF-1R) is unquestionable, the predominating single factor. IGF-1R is crucial for tumour transformation and survival of malignant cell, but is only partially involved in normal ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Larsson, O, Girnita, A, Girnita, L
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2005
Materias:	Minireview
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361813/ https://www.ncbi.nlm.nih.gov/pubmed/15956962 http://dx.doi.org/10.1038/sj.bjc.6602627

Ejemplares similares

Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulation
por: Girnita, Leonard, et al.
Publicado: (2013)

RETRACTED ARTICLE:Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor
por: Girnita, A, et al.
Publicado: (2011)

Role of Ubiquitination in IGF-1 Receptor Signaling and Degradation
por: Sehat, Bita, et al.
Publicado: (2007)

Insulin-like growth factors and insulin control a multifunctional signalling network of significant importance in cancer
por: Massoner, P, et al.
Publicado: (2010)

Targeting insulin-like growth factor pathways
por: Yee, D
Publicado: (2006)

Targeting the IGF-1R: The Tale of the Tortoise and the Hare
por: Crudden, Caitrin, et al.
Publicado: (2015)

Stage debut for the elusive Drosophila insulin-like growth factor binding protein
por: Alic, Nazif, et al.
Publicado: (2008)

Functional antagonism of β-arrestin isoforms balance IGF-1R expression and signalling with distinct cancer-related biological outcomes
por: Suleymanova, N, et al.
Publicado: (2017)

Enhanced response of melanoma cells to MEK inhibitors following unbiased IGF-1R down-regulation
por: Suleymanova, Naida, et al.
Publicado: (2017)

Fixed-ratio combinations of basal insulin and glucagon-like peptide-1 receptor agonists as a promising strategy for treating diabetes
por: Nomoto, Hiroshi
Publicado: (2023)

Shrinkage control: regulation of insulin-mediated growth by FOXO transcription factors
por: Neufeld, Thomas P
Publicado: (2003)

Targeting the epidermal growth factor receptor
por: El-Rayes, B F, et al.
Publicado: (2004)

Role of insulin and insulin resistance in androgen excess disorders
por: Unluhizarci, Kursad, et al.
Publicado: (2021)

Epidermal growth factor signalling and bone metastasis
por: Lu, X, et al.
Publicado: (2010)

Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth
por: Traish, A M, et al.
Publicado: (2009)

Below the Surface: IGF-1R Therapeutic Targeting and Its Endocytic Journey
por: Crudden, Caitrin, et al.
Publicado: (2019)

Unbalancing p53/Mdm2/IGF-1R axis by Mdm2 activation restrains the IGF-1-dependent invasive phenotype of skin melanoma
por: Worrall, C, et al.
Publicado: (2017)

Real role of growth factor receptor-binding protein 10: Linking lipid metabolism to diabetes cardiovascular complications
por: Yang, Yang, et al.
Publicado: (2022)

Role of netrin-1 and netrin-1 dependence receptors in colorectal cancers
por: Mehlen, P, et al.
Publicado: (2005)

Biomarkers of clinical benefit for anti-epidermal growth factor receptor agents in patients with non-small-cell lung cancer
por: Pallis, A G, et al.
Publicado: (2011)

Recent Progress in Regulation of Aging by Insulin/IGF-1 Signaling in Caenorhabditis elegans
por: Lee, Hanseul, et al.
Publicado: (2022)

Role of selenium in type 2 diabetes, insulin resistance and insulin secretion
por: Casanova, Pilar, et al.
Publicado: (2023)

Tyrosine kinase inhibitors and human epidermal growth factor receptor-2 positive breast cancer
por: Abunada, Aya, et al.
Publicado: (2023)

Editorial: DNA damage response pathways meet endocrine systems
por: Werner, Haim, et al.
Publicado: (2023)

Deciphering Brain Insulin Receptor and Insulin‐Like Growth Factor 1 Receptor Signalling
por: Kleinridders, A.
Publicado: (2016)

Human epidermal growth factor receptor 2 targeted therapy in endometrial cancer: Clinical and pathological perspectives
por: Saito, Ayumi, et al.
Publicado: (2021)

Role of Insulin-like Growth Factor, Insulin-like Growth Factor Receptors, and Insulin-like Growth Factor-binding Proteins in Ovarian Cancer
por: Amutha, Periyasamy, et al.
Publicado: (2017)

Diabetes and COVID-19: Role of insulin resistance as a risk factor for COVID-19 severity
por: Gangadharan, Charitha, et al.
Publicado: (2021)

New role for ceramide in hypoxia and insulin resistance
por: Xia, Qing-Song, et al.
Publicado: (2020)

It Takes Two to Tango: IGF-I and TSH Receptors in Thyroid Eye Disease
por: Girnita, Leonard, et al.
Publicado: (2022)

Gefitinib (‘Iressa’, ZD1839) and new epidermal growth factor receptor inhibitors
por: Blackledge, G, et al.
Publicado: (2004)

Liquid biopsy to detect resistance mutations against anti-epidermal growth factor receptor therapy in metastatic colorectal cancer
por: Valenzuela, Guillermo, et al.
Publicado: (2022)

Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword?
por: Killeen, S D, et al.
Publicado: (2006)

Development of therapeutic options on type 2 diabetes in years: Glucagon-like peptide-1 receptor agonist’s role intreatment; from the past to future
por: Dogruel, Hakan, et al.
Publicado: (2019)

Non-Coding RNAs in IGF-1R Signaling Regulation: The Underlying Pathophysiological Link between Diabetes and Cancer
por: Chen, Baoqing, et al.
Publicado: (2019)

Transcription factors specificity protein and nuclear receptor 4A1 in pancreatic cancer
por: Safe, Stephen, et al.
Publicado: (2021)

Recent advances and new insights in the management of early-stage epidermal growth factor receptor-mutated non-small-cell lung cancer
por: Sotelo, Miguel J, et al.
Publicado: (2021)

Review of epidermal growth factor receptor-tyrosine kinase inhibitors administration to non-small-cell lung cancer patients undergoing hemodialysis
por: Lan, Chou-Chin, et al.
Publicado: (2022)

Glucagon-like peptide-1 receptor agonists favorably address all components of metabolic syndrome
por: Chatterjee, Sanjay, et al.
Publicado: (2016)

Glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: An update
por: Sofogianni, Areti, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jlq6d0gp5vi3i7ubtjesapaja3